<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>IXJ filings -- what changed, from SEC Form N-PORT | Mulden</title><description>Each N-PORT filing of IXJ compared with the one before: positions added and dropped, the largest weight changes, turnover. Computed by Mulden from the filings; dated by filing period and SEC receipt.</description><link>https://themulden.com/</link><language>en</language><item><title>IXJ: filing for 2026-06-30 -- 4 added, 5 dropped, turnover 6.6%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>124 positions became 123: 4 added (0.37% of the fund), 5 dropped (0.43%). Turnover proxy 6.6%. Largest increases: ELI LILLY AND COMPANY 9.47% to 10.95%; UNITEDHEALTH GROUP INCORPORATED 3.26% to 4.4%; CVS HEALTH CORPORATION 1.22% to 1.72%; NOVO NORDISK A/S 1.55% to 1.99%; HUMANA INC. 0.28% to 0.62%; ELEVANCE HEALTH, INC. 0.86% to 1.09%. Largest decreases: JOHNSON &amp;amp; JOHNSON 7.66% to 7.05%; BOSTON SCIENTIFIC CORPORATION 1.24% to 0.82%; INTUITIVE SURGICAL, INC. 2.18% to 1.83%; PFIZER INC. 2.12% to 1.78%; ABBOTT LABORATORIES 2.37% to 2.06%; ZOETIS INC. 0.66% to 0.39%. New: VEEVA SYSTEMS INC. (0.35%), XAV HEALTH CARE SEP26 (0.02%), SWISS FRANC (0.01%), HOLOGIC INC CVR (0%). Gone: HOLOGIC, INC. (0.22%), Pro Medicus Ltd (0.06%), M3, Inc. (0.06%), SYSMEX CORPORATION (0.06%), Zealand Pharma A/S (0.04%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 24 Aug 2026 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2026-03-31 -- 2 added, 5 dropped, turnover 10.1%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>127 positions became 124: 2 added (3.84% of the fund), 5 dropped (3.92%). Turnover proxy 10.1%. Largest increases: JOHNSON &amp;amp; JOHNSON 6.31% to 7.66%; MERCK &amp;amp; CO., INC. 3.31% to 3.97%; Novartis AG 3.31% to 3.88%; ASTRAZENECA PLC 3.63% to 4.03%; GILEAD SCIENCES, INC. 1.92% to 2.3%; PFIZER INC. 1.79% to 2.12%. Largest decreases: ELI LILLY AND COMPANY 10.8% to 9.47%; BOSTON SCIENTIFIC CORPORATION 1.79% to 1.24%; UNITEDHEALTH GROUP INCORPORATED 3.78% to 3.26%; NOVO NORDISK A/S 2.05% to 1.55%; ABBOTT LABORATORIES 2.75% to 2.37%; INTUITIVE SURGICAL, INC. 2.54% to 2.18%. New: Roche Holding AG (3.73%), Qiagen N.V. (0.11%). Gone: Roche Holding AG (3.67%), Qiagen N.V. (0.12%), MOLINA HEALTHCARE, INC. (0.12%), SWISS FRANC (0%), XAV HEALTH CARE MAR26 (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 22 May 2026 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2025-12-31 -- 12 added, 1 dropped, turnover 5.5%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>116 positions became 127: 12 added (0.04% of the fund), 1 dropped (0%). Turnover proxy 5.5%. Largest increases: ELI LILLY AND COMPANY 8.44% to 10.8%; Roche Holding AG 3.25% to 3.67%; MERCK &amp;amp; CO., INC. 2.92% to 3.31%; ASTRAZENECA PLC 3.31% to 3.63%; INTUITIVE SURGICAL, INC. 2.23% to 2.54%; THERMO FISHER SCIENTIFIC INCORPORATED 2.55% to 2.76%. Largest decreases: ABBVIE INC. 5.69% to 5.11%; UNITEDHEALTH GROUP INCORPORATED 4.35% to 3.78%; ABBOTT LABORATORIES 3.24% to 2.75%; NOVO NORDISK A/S 2.47% to 2.05%; STRYKER CORPORATION 1.77% to 1.53%; PFIZER INC. 2.02% to 1.79%. New: BRAZILIAN REAL (0.01%), EURO (0.01%), JAPANESE YEN (0%), AUSTRALIAN DOLLAR (0%), DANISH KRONER (0%), HONG KONG DOLLAR (0%). Gone: Chicago Mercantile Exchange (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2025-09-30 -- 2 added, 1 dropped, turnover 5.2%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>115 positions became 116: 2 added (0.35% of the fund), 1 dropped (0.19%). Turnover proxy 5.2%. Largest increases: AbbVie Inc 4.69% to 5.69%; Johnson &amp;amp; Johnson 5.26% to 6.21%; Thermo Fisher Scientific Inc 2.19% to 2.55%; UnitedHealth Group Inc 4.05% to 4.35%; AstraZeneca PLC 3.09% to 3.31%; EssilorLuxottica SA 1.13% to 1.32%. Largest decreases: Novo Nordisk A/S 3.13% to 2.47%; Intuitive Surgical Inc 2.79% to 2.23%; Eli Lilly &amp;amp; Co 8.77% to 8.44%; Boston Scientific Corp 2.27% to 2.01%; Elevance Health Inc 1.26% to 1.01%; Vertex Pharmaceuticals Inc 1.63% to 1.4%. New: BeOne Medicines Ltd (0.35%), Chicago Mercantile Exchange (0%). Gone: Samsung Biologics Co Ltd (0.19%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 26 Nov 2025 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2025-06-30 -- 1 added, 1 dropped, turnover 4.9%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>115 positions became 115: 1 added (0.24% of the fund), 1 dropped (0%). Turnover proxy 4.9%. Largest increases: Intuitive Surgical Inc 2.39% to 2.79%; Novartis AG 2.98% to 3.3%; Abbott Laboratories 3.12% to 3.39%; Boston Scientific Corp 2.02% to 2.27%; Stryker Corp 1.73% to 1.94%; Novo Nordisk A/S 2.92% to 3.13%. Largest decreases: UnitedHealth Group Inc 6.54% to 4.05%; Thermo Fisher Scientific Inc 2.58% to 2.19%; Bristol-Myers Squibb Co 1.7% to 1.35%; Merck &amp;amp; Co Inc 3.09% to 2.84%; Becton Dickinson &amp;amp; Co 0.9% to 0.71%; Sanofi SA 1.66% to 1.48%. New: Galderma Group AG (0.24%). Gone: Chicago Mercantile Exchange (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 26 Aug 2025 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2025-03-31 -- 6 added, 3 dropped, turnover 5.7%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>112 positions became 115: 6 added (1.14% of the fund), 3 dropped (0.33%). Turnover proxy 5.7%. Largest increases: Johnson &amp;amp; Johnson 4.75% to 5.43%; CVS Health Corp 0.82% to 1.16%; Roche Holding AG 2.83% to 3.16%; Abbott Laboratories 2.83% to 3.12%; AbbVie Inc 4.52% to 4.79%; Amgen Inc 2.02% to 2.28%. Largest decreases: Novo Nordisk A/S 3.88% to 2.92%; Merck &amp;amp; Co Inc 3.62% to 3.09%; Danaher Corp 2.13% to 1.78%; Intuitive Surgical Inc 2.68% to 2.39%; Thermo Fisher Scientific Inc 2.87% to 2.58%; Pfizer Inc 2.17% to 1.96%. New: Haleon PLC (0.62%), Samsung Biologics Co Ltd (0.17%), Sigma Healthcare Ltd (0.14%), QIAGEN NV (0.11%), Pro Medicus Ltd (0.09%), Chicago Mercantile Exchange (0%). Gone: QIAGEN NV (0.15%), Teleflex Inc (0.12%), Ramsay Health Care Ltd (0.06%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 28 May 2025 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2024-12-31 -- 0 added, 1 dropped, turnover 4.1%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>113 positions became 112: 0 added (0% of the fund), 1 dropped (0.14%). Turnover proxy 4.1%. Largest increases: Intuitive Surgical Inc 2.2% to 2.68%; Gilead Sciences Inc 1.32% to 1.66%; Boston Scientific Corp 1.56% to 1.9%; Bristol-Myers Squibb Co 1.32% to 1.65%; Abbott Laboratories 2.5% to 2.83%; McKesson Corp 0.81% to 1.04%. Largest decreases: Novo Nordisk A/S 4.72% to 3.88%; Regeneron Pharmaceuticals Inc 1.41% to 1.08%; Elevance Health Inc 1.52% to 1.23%; CVS Health Corp 1% to 0.82%; Amgen Inc 2.19% to 2.02%; HCA Healthcare Inc 0.95% to 0.79%. Gone: Catalent Inc (0.14%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 25 Feb 2025 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2024-09-30 -- 1 added, 2 dropped, turnover 4.7%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>114 positions became 113: 1 added (0.1% of the fund), 2 dropped (0.07%). Turnover proxy 4.7%. Largest increases: UnitedHealth Group Inc 6.21% to 6.81%; AbbVie Inc 4.01% to 4.4%; Roche Holding AG 2.58% to 2.84%; Bristol-Myers Squibb Co 1.12% to 1.32%; Gilead Sciences Inc 1.13% to 1.32%; Thermo Fisher Scientific Inc 2.8% to 2.98%. Largest decreases: Novo Nordisk A/S 6.04% to 4.72%; Eli Lilly &amp;amp; Co 9.57% to 8.82%; Merck &amp;amp; Co Inc 4.16% to 3.63%; Dexcom Inc 0.6% to 0.34%; Moderna Inc 0.52% to 0.29%; Edwards Lifesciences Corp 0.74% to 0.51%. New: Zealand Pharma A/S (0.1%). Gone: Bio-Rad Laboratories Inc (0.07%), Chicago Mercantile Exchange (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 26 Nov 2024 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2024-06-30 -- 2 added, 3 dropped, turnover 5%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>115 positions became 114: 2 added (0.32% of the fund), 3 dropped (0.64%). Turnover proxy 5%. Largest increases: Eli Lilly &amp;amp; Co 8.19% to 9.57%; Novo Nordisk A/S 5.46% to 6.04%; AstraZeneca PLC 2.74% to 3.2%; Intuitive Surgical Inc 1.85% to 2.09%; Amgen Inc 2% to 2.22%; Roche Holding AG 2.37% to 2.58%. Largest decreases: Bristol-Myers Squibb Co 1.49% to 1.12%; CVS Health Corp 1.33% to 0.98%; Merck &amp;amp; Co Inc 4.46% to 4.16%; AbbVie Inc 4.26% to 4.01%; Abbott Laboratories 2.6% to 2.4%; Johnson &amp;amp; Johnson 4.74% to 4.57%. New: Labcorp Holdings Inc (0.23%), Solventum Corp (0.1%). Gone: Illumina Inc (0.29%), Laboratory Corp of America Holdings (0.26%), DENTSPLY SIRONA Inc (0.09%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 26 Aug 2024 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2024-03-31 -- 2 added, 3 dropped, turnover 5.9%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>116 positions became 115: 2 added (0.39% of the fund), 3 dropped (0.59%). Turnover proxy 5.9%. Largest increases: Eli Lilly &amp;amp; Co 6.54% to 8.19%; Novo Nordisk A/S 4.71% to 5.46%; Merck &amp;amp; Co Inc 3.89% to 4.46%; AbbVie Inc 3.85% to 4.26%; Intuitive Surgical Inc 1.67% to 1.85%; Stryker Corp 1.43% to 1.59%. Largest decreases: UnitedHealth Group Inc 6.86% to 6.03%; Johnson &amp;amp; Johnson 5.31% to 4.74%; Roche Holding AG 2.88% to 2.37%; Novartis AG 2.95% to 2.66%; Zoetis Inc 1.28% to 1.03%; Humana Inc 0.79% to 0.56%. New: Cooper Cos Inc/The (0.26%), QIAGEN NV (0.12%). Gone: Cooper Cos Inc/The (0.26%), Wuxi Biologics Cayman Inc (0.19%), QIAGEN NV (0.14%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 28 May 2024 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2023-12-31 -- 2 added, 1 dropped, turnover 3.5%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>115 positions became 116: 2 added (0.2% of the fund), 1 dropped (0.06%). Turnover proxy 3.5%. Largest increases: Novo Nordisk A/S 4.35% to 4.71%; Eli Lilly &amp;amp; Co 6.34% to 6.54%; Abbott Laboratories 2.49% to 2.69%; Celltrion Inc 0.18% to 0.35%; CSL Ltd 1.15% to 1.33%; Intuitive Surgical Inc 1.52% to 1.67%. Largest decreases: Pfizer Inc 2.77% to 2.29%; Bristol-Myers Squibb Co 1.8% to 1.47%; Danaher Corp 2.41% to 2.14%; Johnson &amp;amp; Johnson 5.55% to 5.31%; Sanofi SA 1.77% to 1.56%; Novartis AG 3.13% to 2.95%. New: Sandoz Group AG (0.19%), Chicago Mercantile Exchange (0.01%). Gone: Organon &amp;amp; Co (0.06%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 26 Feb 2024 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2023-09-30 -- 1 added, 2 dropped, turnover 8.6%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>116 positions became 115: 1 added (4.35% of the fund), 2 dropped (3.7%). Turnover proxy 8.6%. Largest increases: Eli Lilly &amp;amp; Co 5.24% to 6.34%; UnitedHealth Group Inc 6.34% to 6.92%; AbbVie Inc 3.37% to 3.9%; Amgen Inc 1.68% to 2.13%; Regeneron Pharmaceuticals Inc 1.1% to 1.31%; Danaher Corp 2.26% to 2.41%. Largest decreases: Johnson &amp;amp; Johnson 6.1% to 5.55%; Novartis AG 3.44% to 3.13%; Merck &amp;amp; Co Inc 4.15% to 3.87%; Roche Holding AG 3.04% to 2.84%; Abbott Laboratories 2.68% to 2.49%; Edwards Lifesciences Corp 0.81% to 0.62%. New: Novo Nordisk A/S (4.35%). Gone: Novo Nordisk A/S (3.7%), Chicago Mercantile Exchange (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 28 Nov 2023 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2023-06-30 -- 0 added, 0 dropped, turnover 4.5%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>116 positions became 116: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 4.5%. Largest increases: Eli Lilly &amp;amp; Co 3.92% to 5.24%; Intuitive Surgical Inc 1.3% to 1.7%; Merck &amp;amp; Co Inc 3.9% to 4.15%; Novartis AG 3.19% to 3.44%; Johnson &amp;amp; Johnson 5.86% to 6.1%; Roche Holding AG 2.9% to 3.04%. Largest decreases: AbbVie Inc 4.08% to 3.37%; Thermo Fisher Scientific Inc 3.27% to 2.85%; Pfizer Inc 3.31% to 2.94%; Bristol-Myers Squibb Co 2.13% to 1.9%; Amgen Inc 1.87% to 1.68%; Regeneron Pharmaceuticals Inc 1.28% to 1.1%. Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 25 Aug 2023 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2023-03-31 -- 3 added, 1 dropped, turnover 4.9%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>114 positions became 116: 3 added (0.76% of the fund), 1 dropped (0.05%). Turnover proxy 4.9%. Largest increases: Novo Nordisk A/S 3.16% to 3.76%; Sanofi 1.58% to 1.8%; Stryker Corp 1.17% to 1.39%; Thermo Fisher Scientific Inc 3.07% to 3.27%; Bayer AG 0.72% to 0.91%; Regeneron Pharmaceuticals Inc 1.1% to 1.28%. Largest decreases: Pfizer Inc 4.08% to 3.31%; Johnson &amp;amp; Johnson 6.56% to 5.86%; UnitedHealth Group Inc 7.03% to 6.39%; CVS Health Corp 1.73% to 1.38%; Cigna Group/The 1.44% to 1.1%; Roche Holding AG 3.13% to 2.9%. New: GE HealthCare Technologies Inc (0.43%), Insulet Corp (0.32%), Chicago Mercantile Exchange (0.01%). Gone: GN Store Nord AS (0.05%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 25 May 2023 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2022-12-31 -- 0 added, 1 dropped, turnover 4.3%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>115 positions became 114: 0 added (0% of the fund), 1 dropped (0.18%). Turnover proxy 4.3%. Largest increases: Novo Nordisk A/S 2.61% to 3.16%; Merck &amp;amp; Co Inc 3.49% to 3.99%; Gilead Sciences Inc 1.24% to 1.53%; Intuitive Surgical Inc 1.07% to 1.34%; AbbVie Inc 3.79% to 4.06%; AstraZeneca PLC 2.72% to 2.98%. Largest decreases: Roche Holding AG 3.66% to 3.13%; UnitedHealth Group Inc 7.55% to 7.03%; Johnson &amp;amp; Johnson 6.87% to 6.56%; CVS Health Corp 2% to 1.73%; Bristol-Myers Squibb Co 2.43% to 2.17%; Medtronic PLC 1.72% to 1.47%. Gone: ABIOMED Inc (0.18%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 24 Feb 2023 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2022-09-30 -- 2 added, 4 dropped, turnover 5.2%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>117 positions became 115: 2 added (1.59% of the fund), 4 dropped (1.76%). Turnover proxy 5.2%. Largest increases: UnitedHealth Group Inc 7.13% to 7.55%; Eli Lilly &amp;amp; Co 3.79% to 4.08%; Danaher Corp 2.43% to 2.7%; Regeneron Pharmaceuticals Inc 0.95% to 1.18%; CVS Health Corp 1.8% to 2%; Daiichi Sankyo Co Ltd 0.69% to 0.87%. Largest decreases: Pfizer Inc 4.36% to 3.93%; Sanofi 1.72% to 1.4%; AstraZeneca PLC 3.03% to 2.72%; AbbVie Inc 4.01% to 3.79%; Bayer AG 0.87% to 0.72%; Abbott Laboratories 2.82% to 2.71%. New: GSK PLC (0.92%), EssilorLuxottica SA (0.66%). Gone: GSK PLC (1.6%), Vifor Pharma AG (0.12%), Bausch Health Cos Inc (0.04%), Chicago Mercantile Exchange (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 25 Nov 2022 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2022-06-30 -- 1 added, 2 dropped, turnover 5.5%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>118 positions became 117: 1 added (0.2% of the fund), 2 dropped (0.63%). Turnover proxy 5.5%. Largest increases: Eli Lilly &amp;amp; Co 3.11% to 3.79%; Merck &amp;amp; Co Inc 2.84% to 3.42%; UnitedHealth Group Inc 6.58% to 7.13%; Johnson &amp;amp; Johnson 6.39% to 6.92%; Pfizer Inc 3.98% to 4.36%; Bristol-Myers Squibb Co 2.18% to 2.43%. Largest decreases: Intuitive Surgical Inc 1.48% to 1.07%; Roche Holding AG 3.81% to 3.48%; Illumina Inc 0.75% to 0.42%; Medtronic PLC 2.04% to 1.78%; HCA Healthcare Inc 0.82% to 0.57%; Dexcom Inc 0.68% to 0.43%. New: Straumann Holding AG (0.2%). Gone: Cerner Corp (0.38%), Straumann Holding AG (0.25%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 25 Aug 2022 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2022-03-31 -- 2 added, 4 dropped, turnover 5.5%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>120 positions became 118: 2 added (0.38% of the fund), 4 dropped (0.2%). Turnover proxy 5.5%. Largest increases: AbbVie Inc 3.16% to 3.92%; Johnson &amp;amp; Johnson 5.95% to 6.39%; AstraZeneca PLC 2.4% to 2.81%; Bristol-Myers Squibb Co 1.83% to 2.18%; UnitedHealth Group Inc 6.25% to 6.58%; Merck &amp;amp; Co Inc 2.56% to 2.84%. Largest decreases: Abbott Laboratories 3.3% to 2.87%; Pfizer Inc 4.37% to 3.98%; Moderna Inc 1.18% to 0.83%; Zoetis Inc 1.53% to 1.22%; Thermo Fisher Scientific Inc 3.47% to 3.19%; Intuitive Surgical Inc 1.69% to 1.48%. New: Molina Healthcare Inc (0.27%), Vifor Pharma AG (0.11%). Gone: Vifor Pharma AG (0.11%), Ambu A/S (0.06%), Canopy Growth Corp (0.03%), AstraZeneca PLC (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 26 May 2022 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2021-12-31 -- 2 added, 0 dropped, turnover 5.2%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>118 positions became 120: 2 added (0.14% of the fund), 0 dropped (0%). Turnover proxy 5.2%. Largest increases: UnitedHealth Group Inc 5.27% to 6.25%; Pfizer Inc 3.45% to 4.37%; AbbVie Inc 2.73% to 3.16%; Abbott Laboratories 3% to 3.3%; Eli Lilly &amp;amp; Co 2.63% to 2.9%; Thermo Fisher Scientific Inc 3.22% to 3.47%. Largest decreases: Moderna Inc 1.93% to 1.18%; Medtronic PLC 2.41% to 1.84%; AstraZeneca PLC 2.68% to 2.4%; Wuxi Biologics Cayman Inc 0.76% to 0.51%; Takeda Pharmaceutical Co Ltd 0.74% to 0.57%; Merck &amp;amp; Co Inc 2.73% to 2.56%. New: Getinge AB (0.13%), Chicago Mercantile Exchange (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 25 Feb 2022 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2021-09-30 -- 4 added, 3 dropped, turnover 5.4%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>117 positions became 118: 4 added (2.34% of the fund), 3 dropped (0.68%). Turnover proxy 5.4%. Largest increases: AstraZeneca PLC 2.3% to 2.68%; Thermo Fisher Scientific Inc 2.9% to 3.22%; Danaher Corp 2.49% to 2.77%; Novo Nordisk A/S 1.99% to 2.27%; Pfizer Inc 3.2% to 3.45%; Dexcom Inc 0.6% to 0.76%. Largest decreases: Novartis AG 3.29% to 2.86%; Amgen Inc 2.05% to 1.73%; Bristol-Myers Squibb Co 2.18% to 1.88%; Johnson &amp;amp; Johnson 6.34% to 6.08%; UnitedHealth Group Inc 5.52% to 5.27%; Cigna Corp 1.19% to 0.97%. New: Moderna Inc (1.93%), Bio-Techne Corp (0.27%), Rede D&apos;Or Sao Luiz SA (0.13%), AstraZeneca PLC (0%). Gone: Alexion Pharmaceuticals Inc (0.59%), Perrigo Co PLC (0.09%), Chicago Mercantile Exchange (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 24 Nov 2021 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2021-06-30 -- 3 added, 2 dropped, turnover 4.1%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>116 positions became 117: 3 added (0.48% of the fund), 2 dropped (0.31%). Turnover proxy 4.1%. Largest increases: Eli Lilly &amp;amp; Co 2.35% to 2.67%; Roche Holding AG 3.61% to 3.87%; Danaher Corp 2.26% to 2.49%; Wuxi Biologics Cayman Inc 0.65% to 0.87%; AstraZeneca PLC 2.08% to 2.3%; Intuitive Surgical Inc 1.38% to 1.59%. Largest decreases: Johnson &amp;amp; Johnson 6.84% to 6.34%; Abbott Laboratories 3.36% to 3.01%; Daiichi Sankyo Co Ltd 0.84% to 0.58%; Amgen Inc 2.27% to 2.05%; Merck &amp;amp; Co Inc 3.09% to 2.88%; Koninklijke Philips NV 0.83% to 0.66%. New: Charles River Laboratories International Inc (0.27%), Organon &amp;amp; Co (0.11%), Ambu A/S (0.1%). Gone: Varian Medical Systems Inc (0.25%), Galapagos NV (0.06%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 26 Aug 2021 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2021-03-31 -- 2 added, 0 dropped, turnover 3.2%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>114 positions became 116: 2 added (0.35% of the fund), 0 dropped (0%). Turnover proxy 3.2%. Largest increases: Abbott Laboratories 3.09% to 3.36%; UnitedHealth Group Inc 5.29% to 5.57%; Johnson &amp;amp; Johnson 6.59% to 6.84%; Eli Lilly and Co 2.13% to 2.35%; Cigna Corp 1.2% to 1.35%; CVS Health Corp 1.42% to 1.56%. Largest decreases: Novartis AG 3.71% to 3.35%; Roche Holding AG 3.91% to 3.61%; Merck &amp;amp; Co Inc 3.29% to 3.09%; M3 Inc 0.64% to 0.47%; Intuitive Surgical Inc 1.53% to 1.38%; Daiichi Sankyo Co Ltd 1% to 0.84%. New: Eurofins Scientific SE (0.19%), Sartorius Stedim Biotech (0.16%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 27 May 2021 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2020-12-31 -- 3 added, 2 dropped, turnover 4.8%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>113 positions became 114: 3 added (1.16% of the fund), 2 dropped (0.53%). Turnover proxy 4.8%. Largest increases: AbbVie Inc 2.63% to 3.01%; UnitedHealth Group Inc 5.04% to 5.29%; Align Technology Inc 0.4% to 0.61%; M3 Inc 0.45% to 0.64%; Celltrion Inc 0.36% to 0.52%; Cigna Corp 1.06% to 1.2%. Largest decreases: Amgen Inc 2.53% to 2.14%; AstraZeneca PLC 2.44% to 2.09%; Merck &amp;amp; Co Inc 3.57% to 3.29%; Vertex Pharmaceuticals Inc 1.21% to 0.98%; Pfizer Inc 3.47% to 3.25%; Sanofi 1.95% to 1.76%. New: Wuxi Biologics Cayman Inc (0.61%), Viatris Inc (0.36%), Siemens Healthineers AG (0.18%). Gone: Wuxi Biologics Cayman Inc (0.4%), Mylan NV (0.13%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 25 Feb 2021 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2020-09-30 -- 3 added, 0 dropped, turnover 4.8%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>110 positions became 113: 3 added (0.82% of the fund), 0 dropped (0%). Turnover proxy 4.8%. Largest increases: Thermo Fisher Scientific Inc 2.56% to 2.97%; Abbott Laboratories 2.89% to 3.28%; Danaher Corp 1.99% to 2.31%; Intuitive Surgical Inc 1.19% to 1.41%; Pfizer Inc 3.25% to 3.47%; Medtronic PLC 2.2% to 2.38%. Largest decreases: Eli Lilly and Co 2.47% to 2%; AbbVie Inc 3.09% to 2.63%; Gilead Sciences Inc 1.73% to 1.35%; Bayer AG 1.3% to 1.05%; Roche Holding AG 4.35% to 4.1%; CVS Health Corp 1.52% to 1.3%. New: Wuxi Biologics Cayman Inc (0.4%), Catalent Inc (0.24%), GN Store Nord A/S (0.18%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 25 Nov 2020 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2020-06-30 -- 5 added, 1 dropped, turnover 5.7%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>106 positions became 110: 5 added (1.53% of the fund), 1 dropped (1.18%). Turnover proxy 5.7%. Largest increases: AbbVie Inc 2.29% to 3.09%; Regeneron Pharmaceuticals Inc 0.79% to 1.12%; Thermo Fisher Scientific Inc 2.32% to 2.56%; UnitedHealth Group Inc 4.81% to 5%; Danaher Corp 1.8% to 1.99%; Illumina Inc 0.82% to 0.97%. Largest decreases: Merck &amp;amp; Co Inc 3.99% to 3.49%; Novartis AG 4.29% to 3.84%; Pfizer Inc 3.68% to 3.25%; Johnson &amp;amp; Johnson 7.03% to 6.62%; Biogen Inc 1.16% to 0.78%; Roche Holding AG 4.64% to 4.35%. New: DexCom Inc (0.67%), West Pharmaceutical Services Inc (0.3%), Sartorius AG (0.2%), Argenx SE (0.19%), Bio-Rad Laboratories Inc (0.17%). Gone: Allergan PLC (1.18%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 27 Aug 2020 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2020-03-31 -- 0 added, 1 dropped, turnover 4.5%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>107 positions became 106: 0 added (0% of the fund), 1 dropped (0.3%). Turnover proxy 4.5%. Largest increases: Roche Holding AG 4.08% to 4.64%; Gilead Sciences Inc 1.48% to 1.93%; Eli Lilly &amp;amp; Co 1.99% to 2.39%; Novo Nordisk A/S 1.72% to 2.03%; Regeneron Pharmaceuticals Inc 0.54% to 0.79%; Vertex Pharmaceuticals Inc 1% to 1.25%. Largest decreases: Medtronic PLC 2.73% to 2.46%; HCA Healthcare Inc 0.7% to 0.48%; Pfizer Inc 3.89% to 3.68%; Bayer AG 1.37% to 1.16%; Boston Scientific Corp 1.13% to 0.93%; Anthem Inc 1.37% to 1.17%. Gone: WellCare Health Plans Inc (0.3%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 01 Jun 2020 12:00:00 GMT</pubDate></item><item><title>IXJ: filing for 2019-12-31 -- 1 added, 2 dropped, turnover 4.5%</title><link>https://themulden.com/funds/ixj/</link><guid isPermaLink="true">https://themulden.com/funds/ixj/</guid><description>108 positions became 107: 1 added (0.23% of the fund), 2 dropped (1.48%). Turnover proxy 4.5%. Largest increases: Bristol-Myers Squibb Co 1.67% to 2.7%; UnitedHealth Group Inc 4.13% to 4.99%; Amgen Inc 2.33% to 2.57%; Cigna Corp 1.15% to 1.37%; Humana Inc 0.7% to 0.87%; Anthem Inc 1.23% to 1.37%. Largest decreases: Chicago Mercantile Exchange 0.33% to 0%; Abbott Laboratories 2.98% to 2.75%; Medtronic PLC 2.93% to 2.73%; Merck &amp;amp; Co Inc 4.33% to 4.15%; Stryker Corp 1.39% to 1.21%; Gilead Sciences Inc 1.61% to 1.48%. New: STERIS PLC (0.23%). Gone: Celgene Corp (1.41%), Nektar Therapeutics (0.06%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 27 Feb 2020 12:00:00 GMT</pubDate></item></channel></rss>